To test this hypothesis, we treated vascular endothelial cells and rats with simvastatin in diabetic condition and observed the NLRP3 inflammasome and changes of vascular permeability which is a common pathogenic change during the development of chronic inflammation such as type 2 diabetes [17]. Here, NLRP3 is linked to type 2 diabetes mellitus.